MK-9470

MK-9470
MK-9470
MK-9470.svg
이름
선호 IUPAC 이름
N-[(2S,3S)-3-(3-Cyanophenyl)-3-(3-Cyanophenyl)-4-(4-ethoxypenyl)부탄-2-yl]-2-메틸-2-[(5-methylpyridin-2-yl)yl]propamanide
식별자
3D 모델(JSmol)
켐스파이더
펍켐 CID
유니
  • InChI=1S/C29H33N3O3/c1-6-34-25-13-11-22(12-14-25)17-26(24-9-7-8-23(16-24)18-30)21(3)32-28(33)29(4,5)35-27-15-10-20(2)19-31-27/h7-16,19,21,26H,6,17H2,1-5H3,(H,32,33)/t21-,26+/m0/s1 ☒N
    키: JWBGLSNXGRDLKH-HFZDXHNSA-N ☒N
  • InChI=1/C29H33N3O3/c1-6-34-25-13-11-22(12-14-25)17-26(24-9-7-8-23(16-24)18-30)21(3)32-28(33)29(4,5)35-27-15-10-20(2)19-31-27/h7-16,19,21,26H,6,17H2,1-5H3,(H,32,33)/t21-,26+/m0/s1
    키: JWBGLSNXGRDLKH-HFZDXHNBD
  • CCOC1ccc(C[C@H](C)NC(=O)C(C)OC2ccc(C)cn2)c3ccc(c3)C#N)cc1ccc1
특성.
C29H33N3O3
어금질량 471.59 g/190
달리 명시된 경우를 제외하고, 표준 상태(25°C [77°F], 100 kPa)의 재료에 대한 데이터가 제공된다.
☒ NVERIFI (?란수표Y☒N?
Infobox 참조 자료

MK-9470은 합성 화합물로, CB1 칸나비노이드 수용체결합되어 역작용제로서의 기능을 한다.[1]

참조

  1. ^ Burns, HD; Van Laere, K; Sanabria-Bohórquez, S; Hamill, TG; Bormans, G; Eng, WS; Gibson, R; Ryan, C; Connolly, B; Patel, S; Krause, S; Vanko, A; Van Hecken, A; Dupont, P; De Lepeleire, I; Rothenberg, P; Stoch, SA; Cote, J; Hagmann, WK; Jewell, JP; Lin, LS; Liu, P; Goulet, MT; Gottesdiener, K; Wagner, JA; de Hoon, J; Mortelmans, L; Fong, TM; Hargreaves, RJ (5 June 2007). "[18F] MK-9470, a Positron Emission Tomography (PET) Tracer for in vivo Human PET Brain Imaging of the Cannabinoid-1 Receptor". Proceedings of the National Academy of Sciences of the United States of America. 104 (23): 9800–5. Bibcode:2007PNAS..104.9800B. doi:10.1073/pnas.0703472104. PMC 1877985. PMID 17535893.